Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9186 |
High Similarity |
NPD7074 |
Phase 3 |
0.9075 |
High Similarity |
NPD7472 |
Approved |
0.9017 |
High Similarity |
NPD7054 |
Approved |
0.892 |
High Similarity |
NPD7808 |
Phase 3 |
0.8914 |
High Similarity |
NPD6797 |
Phase 2 |
0.8864 |
High Similarity |
NPD7251 |
Discontinued |
0.8844 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8844 |
High Similarity |
NPD6166 |
Phase 2 |
0.8814 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8743 |
High Similarity |
NPD3818 |
Discontinued |
0.8693 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8596 |
High Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8538 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8525 |
High Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8497 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.848 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8453 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8453 |
Intermediate Similarity |
NPD8312 |
Approved |
0.843 |
Intermediate Similarity |
NPD2801 |
Approved |
0.84 |
Intermediate Similarity |
NPD5494 |
Approved |
0.838 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8343 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8333 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8218 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.8212 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8202 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8171 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8167 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8163 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.815 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8081 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.8081 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.8023 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8022 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7978 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7966 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7938 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7938 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7921 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.791 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7908 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7908 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7908 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7907 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7901 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7898 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7868 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7868 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7839 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7826 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7817 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7816 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7809 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7778 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7759 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7759 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7747 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7744 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7735 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD1653 |
Approved |
0.768 |
Intermediate Similarity |
NPD6534 |
Approved |
0.768 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7677 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7673 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7673 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.766 |
Intermediate Similarity |
NPD7240 |
Approved |
0.766 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7654 |
Intermediate Similarity |
NPD37 |
Approved |
0.7635 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7624 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7624 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7624 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7616 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7568 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7554 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7512 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7512 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.75 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7449 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7449 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7449 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7401 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7401 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7399 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7393 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7374 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7371 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.736 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7353 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7351 |
Intermediate Similarity |
NPD919 |
Approved |
0.7348 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7341 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.731 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.731 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7299 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7264 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7263 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7263 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7263 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7263 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7257 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7228 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD943 |
Approved |
0.7209 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7198 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7191 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7175 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7175 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7167 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8059 |
Phase 3 |
0.7136 |
Intermediate Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7135 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7135 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7135 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7126 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7119 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7093 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7088 |
Intermediate Similarity |
NPD920 |
Approved |
0.7076 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7069 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7069 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7062 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7018 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.699 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD7585 |
Approved |
0.698 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.698 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6978 |
Remote Similarity |
NPD642 |
Clinical (unspecified phase) |
0.6977 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6971 |
Remote Similarity |
NPD447 |
Suspended |
0.6966 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6966 |
Remote Similarity |
NPD2344 |
Approved |
0.6963 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6959 |
Remote Similarity |
NPD7286 |
Phase 2 |
0.6949 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6949 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD7930 |
Approved |
0.6938 |
Remote Similarity |
NPD7583 |
Approved |
0.691 |
Remote Similarity |
NPD5405 |
Approved |
0.691 |
Remote Similarity |
NPD5404 |
Approved |
0.691 |
Remote Similarity |
NPD1551 |
Phase 2 |
0.691 |
Remote Similarity |
NPD5406 |
Approved |
0.691 |
Remote Similarity |
NPD5408 |
Approved |
0.6904 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6897 |
Remote Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.6889 |
Remote Similarity |
NPD1243 |
Approved |
0.6875 |
Remote Similarity |
NPD5710 |
Approved |
0.6875 |
Remote Similarity |
NPD5711 |
Approved |
0.6868 |
Remote Similarity |
NPD643 |
Clinical (unspecified phase) |
0.6854 |
Remote Similarity |
NPD3748 |
Approved |
0.6854 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD6651 |
Approved |
0.6834 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD7177 |
Discontinued |
0.6816 |
Remote Similarity |
NPD6099 |
Approved |
0.6816 |
Remote Similarity |
NPD6100 |
Approved |
0.6813 |
Remote Similarity |
NPD2309 |
Approved |
0.6809 |
Remote Similarity |
NPD6844 |
Discontinued |
0.68 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6798 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6782 |
Remote Similarity |
NPD4287 |
Approved |
0.6761 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6758 |
Remote Similarity |
NPD7907 |
Approved |
0.6758 |
Remote Similarity |
NPD7003 |
Approved |
0.6758 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6758 |
Remote Similarity |
NPD8166 |
Discontinued |
0.6755 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6753 |
Remote Similarity |
NPD5242 |
Approved |
0.6746 |
Remote Similarity |
NPD5006 |
Approved |
0.6746 |
Remote Similarity |
NPD5005 |
Approved |
0.6724 |
Remote Similarity |
NPD9494 |
Approved |
0.6705 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6685
|
Remote Similarity |
NPD5124 |
Phase 1 |